One Small Step Towards Personalized Medicine: CMS Reimbursement Changes in “Doc Fix”
This article was originally published in RPM Report
Executive Summary
CMS is emphasizing coverage of companion diagnostics as a key role it can play in advancing personalized medicine. A couple of add-ons to this year’s “Doc Fix” legislation may help move that effort forward.
You may also be interested in...
The Companion Diagnostics Dilemma
An Institute of Medicine workshop on companion diagnostics suggests that regulatory standards are evolving at FDA to encourage companion diagnostic development. But almost everything else is still a challenge.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
Medicare Reaffirms Faith In Formulary Review Process Ahead Of Part D Changes
Dramatic transformation in the US Medicare Part D benefit design does not require any changes to CMS’ overall approach to reviewing formulary submissions from private drug plan sponsors, the agency says in its final guidance implementing the design changes for 2025.